Q-Gesic en es it fr

Q-Gesic Brand names, Q-Gesic Analogs

Q-Gesic Brand Names Mixture

  • No information avaliable

Q-Gesic Chemical_Formula


Q-Gesic RX_link

No information avaliable

Q-Gesic fda sheet

Q-Gesic msds (material safety sheet)

Q-Gesic Synthesis Reference

No information avaliable

Q-Gesic Molecular Weight

309.469 g/mol

Q-Gesic Melting Point

< 25 oC

Q-Gesic H2O Solubility

Soluble as HCl salt

Q-Gesic State


Q-Gesic LogP


Q-Gesic Dosage Forms

Tablets (oral, 1 mg)

Q-Gesic Indication

Used for the symptomatic treatment of parkinsonism.

Q-Gesic Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Q-Gesic Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Q-Gesic side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Q-Gesic Patient Information

Q-Gesic Organisms Affected

Humans and other mammals